Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides by Glasner, C. (Corinna) et al.
1Scientific RePoRTS | 7: 12211  | DOI:10.1038/s41598-017-12450-z
www.nature.com/scientificreports
Genetic loci of Staphylococcus 
aureus associated with anti-
neutrophil cytoplasmic 
autoantibody (ANCA)-associated 
vasculitides
Corinna Glasner1, Marcus C. de Goffau1, Mirjan M. van Timmeren2, Mirja L. Schulze1, Benita 
Jansen1, Mehri Tavakol3, Willem J. B. van Wamel3, Coen A. Stegeman4, Cees G. M. Kallenberg5, 
Jan P. Arends1, John W. Rossen1, Peter Heeringa  2 & Jan Maarten van Dijl1
The proteinase 3 (PR3)-positive anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis 
(AAV) granulomatosis with polyangiitis (GPA) has been associated with chronic nasal S. aureus carriage, 
which is a risk factor for disease relapse. The present study was aimed at comparing the genetic 
make-up of S. aureus isolates from PR3-ANCA-positive GPA patients with that of isolates from patients 
suffering from myeloperoxidase (MPO)-ANCA-positive AAV, and isolates from healthy controls. Based 
on a DNA microarray-based approach, we show that not only PR3-ANCA-positive GPA patients, but 
also MPO-ANCA-positive AAV patients mainly carried S. aureus types that are prevalent in the general 
population. Nonetheless, our data suggests that MPO-ANCA-associated S. aureus isolates may be 
distinct from healthy control- and PR3-ANCA-associated isolates. Furthermore, several genetic loci 
of S. aureus are associated with either PR3-ANCA- or MPO-ANCA-positive AAV, indicating a possible 
role for pore-forming toxins, such as leukocidins, in PR3-ANCA-positive GPA. Contrary to previous 
studies, no association between AAV and superantigens was detected. Our findings also show that a 
lowered humoral immune response to S. aureus is common for PR3-ANCA- and MPO-ANCA-positive 
AAV. Altogether, our observations imply that the presence or absence of particular virulence genes of S. 
aureus isolates from AAV patients contributes to disease progression and/or relapse.
The systemic autoimmune diseases granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) 
belong to the anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides (AAVs)1. AAVs are 
characterized by the presence of circulating ANCAs and inflammation of small to medium-sized vessels, typically 
affecting lungs and kidneys2. The main targets of ANCAs are proteinase 3 (PR3) and myeloperoxidase (MPO), 
two lysosomal enzymes of neutrophils and monocytes. PR3-ANCAs are predominant in GPA and occur mostly 
in Northern-European patients, whereas MPO-ANCAs are generally associated with MPA and are mostly occur-
ring in patients in Asia and Australia2. Notably, AAVs are multifactorial diseases with numerous contributing 
genetic and environmental factors3,4. Among the latter, microbial upper airway infections have been associated 
with PR3-ANCA-GPA. In particular, 60–70% of PR3-GPA patients are chronic nasal carriers of S. aureus, in 
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contrast to 20–30% of healthy individuals5,6. Moreover, PR3-GPA patients carrying S. aureus have an increased 
risk of disease relapse while anti-bacterial treatment reduces the risk of relapse5,7,8. Accordingly, particular viru-
lence factors of S. aureus, such as the staphylococcal superantigen (SAg) toxic shock syndrome toxin-1 (TSST-1), 
were previously implicated in PR3-ANCA-GPA disease relapse9,10.
We have previously demonstrated that PR3-ANCA-GPA patients carry highly diverse S. aureus types that 
mirror the general S. aureus population11. Yet, this finding does not rule out the possibility that S. aureus car-
ried by PR3-ANCA-positive patients possesses a particular genetic make-up that could contribute to disease 
progression and/or relapse. Studies on S. aureus isolates from MPO-ANCA-positive patients have so far been 
lacking. Therefore, the present study was aimed at investigating the gene repertoire of S. aureus nasal isolates from 
PR3-ANCA-positive patients and to compare it to that of S. aureus isolates from MPO-ANCA-positive patients 
and from healthy controls (HC). Additionally, the humoral immune response of these two AAV patient groups 
against a comprehensive set of S. aureus antigens was compared, because our previous studies had shown that 
GPA patient sera contained lower anti-staphylococcal IgG levels than sera from HC11.
Materials and Methods
Patients, bacterial isolates and serum samples. This retrospective study included S. aureus isolates 
and serum samples from AAV patients and HC with a Caucasian background. All patients fulfilled the Chapel 
Hill Consensus Conference definitions for the diagnosis of AAV and regularly visited the University Medical 
Center Groningen (UMCG, The Netherlands)1. The patients were selected based on availability of stored S. aureus 
isolates and/or serum samples, but formed a representative cohort of all AAV patients from our hospital.
The 61 investigated S. aureus isolates from 32 PR3-ANCA patients and the 18 isolates from 10 HC were 
collected in the period 2006–2012, and have been described in a previous study (Table 1)11. The 27 newly inves-
tigated S. aureus isolates from 27 MPO-ANCA patients were collected in the same period. Characteristics of the 
S. aureus isolates used in this study are summarized in Table 1. Of note, the sample size of S. aureus isolates from 
MPO-ANCA patients is relatively low, primarily because the number of MPO-ANCA patients in the Netherlands 
is much lower than the number of PR3-ANCA patients. In addition, S. aureus isolates from MPO-ANCA patients 
are not routinely frozen in our hospital, in contrast to isolates from PR3-ANCA patients. Further, when more 
than one isolate per patient was included in the analyses, this concerned always different clinical isolates from this 
patient collected at different time points.
IgG responses of PR3-ANCA and MPO-ANCA patients and HC to staphylococcal antigens were determined 
in sera from 27 PR3-ANCA patients (15 S. aureus carriers, 12 non-carriers; one serum/patient), 38 MPO-ANCA 
patients (27 carriers, 11 non-carriers; 1 serum/patient) and 18 HC (10 carriers with 23 sera, eight non-carriers 
with 20 sera).
Ethics statement. All bacterial isolates and human serum samples were obtained from an already-existing 
collection of the ‘Groningen cohort of ANCA-associated vasculitis’, for which institutional review board (IRB) 
approval of the experimental protocols was previously obtained from the Medical Ethics Committee of the 
UMCG. Written informed consent was obtained from all patients, and all experiments were conducted in accord-
ance with the guidelines of the Declaration of Helsinki. All isolates and samples were anonymized.
DNA microarray. DNA was isolated with the UltraClean Microbial DNA Isolation Kit (MoBio, Carlsbad, 
USA). The Clondiag S. aureus Genotyping Kit 2.0 (Alere Technologies GmbH, Jena, Germany) was used for 
DNA microarray analyses12,13. This microarray contains 336 DNA probes to detect genes for species-specific 
markers, antibiotic resistance, SCCmec elements, adhesion and virulence factors, capsule and agr group markers. 
The affiliations of isolates to specific multilocus sequence type clonal complexes (MLST CC) were determined by 
synchronizing the hybridisation profiles to a reference database12.
Multiplex S. aureus antibody assay. Bead-based Luminex flow cytometry (xMAPH, Luminex 
Corporation, Austin, Texas, USA) was performed as previously described14.
Statistical analyses. Statistical analyses were performed with SPSS Statistics 20 (SPSS, Chicago, USA) or 
GraphPad Prism (Version 6, La Jolla, California). Principal component analysis (PCA) was used to describe the 
variation between all three S. aureus isolate groups (i.e. PR3-ANCA, MPO-ANCA and HC) into a very limited 
number of new relevant dimensions in order to address the issue of multiple testing and to identify clusters of 
similar or different gene profiles. Genes that were universally present or absent in all samples from all S. aureus 
isolate groups were excluded from the PCA as they do not describe any variation. Cluster analysis was performed 
using the updated Hierarchical Clustering Explorer 3.0 (HCE), which is publically available at www.cs.umd.hcil/
hce15. Differences in anti-staphylococcal antibody levels between groups were tested for statistical significance 
using the Kruskal-Wallis test. A two-sided p value < 0.05 was considered to be statistically significant.
Results and Discussion
We employed DNA microarrays to determine the genetic profiles of all 106 S. aureus isolates in the PR3-ANCA, 
MPO-ANCA and HC sampling groups. The results of these array analyses underscored the previously reported 
high genetic diversity of PR3-ANCA isolates11, and revealed a comparably high genetic diversity for MPO-ANCA 
isolates. Table 1 summarizes the basic molecular characteristics of the three S. aureus sampling groups, and 
Supplementary Information Table 1 presents all microarray data. As shown in Table 1, the six most common S. 
aureus clonal complexes (CCs) are represented in all three groups of isolates (i.e. PR3-ANCA, MPO-ANCA and 
HC). These six CCs are in fact the most common CCs in Europe16–18. CC8 was predominant amongst PR3-ANCA 
isolates (~46%), while CC30 and CC45 prevailed amongst MPO-ANCA isolates (~19% and ~15%, respectively). 
CC5 and CC7 were both common amongst MPO-ANCA and PR3-ANCA isolates. HC isolates belonged mainly 
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to CC30 (~39%) and the remaining 11 (~61%) isolates were assigned to nine different CCs. Of note, in those 
cases where more than one S. aureus isolate per PR3-ANCA patient or HC was investigated, the microarray data 
showed that this concerned isolates with a different genetic makeup, consistent with the results of spa-typing 
(Table 1).
Identification of potentially disease-associated staphylococcal determinants. Since the 
PR3-ANCA, the MPO-ANCA and the HC isolates represented highly diverse S. aureus types, a PCA was per-
formed that focused on the genetic variation within the CCs identified in these isolate groups. Importantly, the 
location of all 106 S. aureus isolates on the first two principal components (PCs) already explained 62% of the 
variation in the data (Fig. 1). As expected, isolates from the same CC were grouped together (Fig. 1, marked with 
circles). As MPO-ANCA, PR3-ANCA and HC isolates were not evenly distributed amongst CCs, the (indirect) 
PR3-ANCA isolates (n = 61) MPO-ANCA isolates (n = 27) HC isolates (n = 18)
No. of patients 32 27 10
No. of males (%) 22 (69) 11 (41) 4 (40)
Age at time of swab, mean ± SD 55 ± 13 60 ± 13 33.6 ± 11.8
Collection period 2006–2012 2010–2013 2007–2010
spa-types (%)
t002 (1.6) t002 (3.7) t002 (5.6)
t012 (14.8) t012 (16.7)
t021 (1.6) t021 (3.7) t021 (11.1)
t064 (37.7) t064 (3.7)
t091 (21.3) t091 (22.2) t091 (11.1)
t015 (1.6) t026 (7.4) t008 (5.6)
t072 (3.3) t065 (3.7) t024 (5.6)
t089 (3.3) t126 (3.7) t122 (11.1)
t224 (1.6) t223 (7.4) t209 (5.6)
t451 (1.6) t362 (3.7) t230 (5.6)
t539 (6.6) t442 (3.7) t359 (5.6)
t1246 (3.3) t711 (3.7) t2109 (11.1)
t1265 (1.6) t888 (3.7) t6076 (5.6)
t1361 (1.6) t1168 (3.7)
t1508 (3.3) t2849 (3.7)
t2658 (1.6) t6365 (3.7)
t3092 (3.3) t13788 (3.7)
t4584 (1.6)
t12249 (3.3)
CC* strain assignment (%)
CC5 (14.8) CC5 (11.1) CC5 (5.5)
CC7 (21.3) CC7 (22.2) CC7 (11.1)
CC8 (45.9) CC8 (14.8) CC8 (11.1)
CC22 (1.6) CC22 (7.4) CC22 (5.5)
CC30 (4.9) CC30 (18.5) CC30 (38.8)
CC45 (1.6) CC45 (14.8) CC45 (5.5)
CC1 (3.3) CC12 (3.7) CC9 (5.5)
CC25 (3.3) CC361 (3.7) CC20 (11.1)
CC97 (1.6) CC101 (3.7) CC97 (5.5)
None (1.6)
agr type (%)
I (75.4) I (66.7) I (50)
II (14.8) II (14.8) II (11.1)
III (8.2) III (18.5) III (38.9)
None (1.6)
No. of mecA-positive isolates 0 1 0
No. of tst-1-positive isolates 2 5 8
No. of PVL-positive isolates 0 0 0
Table 1. S. aureus isolate characteristics grouped by PR3-ANCA, MPO-ANCA and HC1. 1The 61 isolates 
from 32 PR3-ANCA-positive patients (denoted PR3-ANCA isolates) and 18 isolates from 10 HC (denoted HC 
isolates) have previously been described11,14,26. In addition, 27 nasal S. aureus isolates from 27 MPO-ANCA-
positive patients (denoted MPO-ANCA isolates) visiting our outpatient clinic were collected. At first, all isolates 
were characterized by spa-typing27, revealing that among the MPO-ANCA isolates the spa-types t012, t064 and 
t091 were predominant, similar to the PR3-ANCA and HC collection (Table 1)10. *CC; clonal complexes.
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association of certain staphylococcal genes with PR3-ANCA or MPO-ANCA (indicated in Fig. 1) may relate to 
the association of particular CCs with either of the two disease types.
Other associations with either PR3-ANCA or MPO-ANCA, which are CC-independent, can be found by 
looking at the variation which exists within each clonal complex. For this the average PC1 value of each CC was 
used to calculate the respective position of each isolate on PC1 in comparison with the rest of the isolates that are 
from the same clonal complex group (ΔPC1). This is represented in Fig. 1 by isolates being located more to the 
left or more to the right within a CC circle. PC1 was used for this as it describes nearly half of the variation within 
the entire dataset (45%). In Fig. 2, it is revealed that MPO-ANCA isolates were negatively correlated with ΔPC1, 
i.e. these isolates were shifted to the left within each CC cluster (Fig. 1). Conversely, PR3-ANCA but also the HC 
isolates were positively correlated with ΔPC1, i.e shifted to the right (Fig. 1). This implies that the HC isolates 
have apparently more in common with PR3-ANCA isolates than with MPO-ANCA isolates.
Correlation analyses with ΔPC1 identified several genes associated with PR3-ANCA and HC isolates, but 
not with MPO-ANCA isolates (p < 0.001). These genes include Q2YUB3, lukX, isaB, mprF, set4/ssl10 and set7/
ssl2 (Table 2). Figure 3A displays the prevalence of these six genes plus four genes (cap-5, cap-8, cna and sasG) 
that were associated with PR3-ANCA or MPO-ANCA isolates before the correlation analyses of each CC cluster 
(Fig. 1). Specifically, the cap-5, sasG, Q2YUB3, lukX, isaB, mprF, set4/ssl10 and set7/ssl2 genes were more abun-
dant amongst PR3-ANCA isolates than MPO-ANCA or HC isolates, while the cap-8 and cna genes were less 
abundant amongst PR3-ANCA isolates. However, cap-5, cap-8, cna and sasG are only associated with PR3- or 
MPO-ANCA due to the association of the respective CCs with the two disease types.
Noteworthy, PR3-ANCA isolates can be distinguished to a certain extent from both MPO-ANCA and HC 
isolates by PCA when subsequently analysing only ΔPC2 (Y-axis, Fig. 2), a vector describing 17% of the varia-
tion in the data. A large group of PR3-ANCA isolates score lower on ΔPC2 than all other MPO-ANCA and HC 
isolates (Fig. 2). A lower score on ΔPC2 is in particular strongly associated with the presence of the seb, sed, sek 
and seq genes, with bovine leucocidin, an arginine/ornithine antiporter, fibronectin-binding protein B and the 
Q2FXC0 gene (a putative beta-lactamase) (Fig. 3 and Supplementary Information Table 1). When taking most of 
the variation in the entire dataset together (83%) by doing a hierarchical complete linkage cluster analysis on the 
weighted results of ΔPC1 to ΔPC6, the MPO-ANCA isolates form a very distinct cluster, whereas most of the 
PR3-ANCA isolates are indistinguishable from the HC isolates (Fig. 4). A subset of PR3-ANCA isolates forms a 
distinct cluster in the middle, which sets them slightly apart from the PR3-ANCA/HC cluster on the left because 
the latter do not score high on ΔPC1 and/or score low on ΔPC2 (Fig. 4). Altogether, the PCA analyses suggest 
several interesting associations of genes with the PR3-ANCA or MPO-ANCA isolates, especially genes encoding 
SAgs, leukocidins, hemolysins, enterotoxins and other virulence factors as discussed in the following paragraphs.
Low prevalence of egc– and non-egc genes for SAgs in the two disease-associated sampling 
groups. SAgs are secreted toxins that cause non-specific activation and proliferation of T-cells resulting in 
Figure 1. PCA of the ClonDiag microarray data. The x-axis represents PC1 and the y-axis represents PC2, 
which describes 45% and 17% of all of the variation in the data, respectively. Note that the circle indicating CC7 
also includes five isolates that belong to the different low-abundance CC variants. The same is true for 2 isolates 
in the CC5 circle. The blue and red boxes display single genes or groups of genes that were associated either 
positively with PC1 and negatively with PC2 (red box), or the other way round (blue box). The associations 
with PC1 and PC2 are strongly correlated with the different CCs, of which the abundances differ between PR3-
ANCA, MPO-ANCA and HC. The localization within each CC circle however also shows a clear intra-CC-
specific association of PC1 with either MPO-ANCA (left) or PR3-ANCA and HC (right).
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massive cytokine release. SAgs have therefore been proposed as activators/initiators of various autoimmune dis-
eases10,19,20. For PR3-GPA patients it was previously reported that the carriage of SAg-positive or SAg-negative S. 
aureus isolates was equally associated with an increased risk for disease relapse when compared to non-carriage 
of S. aureus10. In the latter study, only the carriage of tst-1-positive S. aureus, representing 16.5% of the PR3-GPA 
isolates, was associated with a higher risk for disease relapse. In this context, it is remarkable that only 3% of 
the presently investigated PR3-ANCA isolates carried the tst-1 gene (Table 1; Fig. 3B). Conversely, 19% of the 
MPO-ANCA isolates and even 44% of the HC isolates were tst-1-positive (Fig. 3B). In general, ~15–25% of S. 
aureus isolates have been reported tst-1-positive for different S. aureus sampling groups, suggesting that tst-1 is 
underrepresented in our PR3-ANCA isolates16,21. Furthermore, with respect to the overall SAg gene repertoire 
of the three S. aureus sampling groups, we observed an interesting distribution for egc and non-egc genes. Both 
Figure 2. Visualization of the differences in variation (Δ) within each of the six main CCs, as described by 
ΔPC1 (A) and ΔPC2 (B), of PR3-ANCA, MPO-ANCA and HC isolates. Dashed lines represent median values.
Gene name Encoded function
Q2YUB3 multidrug resistance protein
lukX* leukocidin/haemolysin toxin X
isaB* immunodominant antigen B
mprF* probable lysylphophatidylglycerol synthetase (defensin resistance)
set4/ssl10* staphylococcal superantigen-like protein 4
set7/ssl2* staphylococcal superantigen-like protein 7
cap-5 capsular polysaccharide protein 5
cap-8 capsular polysaccharide protein 8
cna collagen-binding adhesion protein
sasG S. aureus surface protein G
Table 2. Genetic loci of S. aureus associated with AAV and functions of the respective proteins. *Associated 
with ΔPC1.
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the egc cluster, consisting of the five SAg genes seg, sei, sem, sen and seo, and the non-egc gene seu were detected 
in only 30–31% of the PR3-ANCA isolates, but in 56–59% of the MPO-ANCA and even in 67–72% of the HC 
isolates (Fig. 3B). The remaining non-egc SAg genes sec, sed, see, seh, sej, sek, sel, seq and ser were detected in a very 
limited number of isolates in either of the three sampling groups (Fig. 3B). Only the non-egc SAg gene sea was 
abundantly detected in the PR3-ANCA isolates.
Other groups have previously reported remarkable variations in the SAg gene profiles, even within S. aureus 
populations possessing the same CC or spa-type19. Thus, it is conceivable that the prevalence of SAg genes in 
the selected S. aureus sampling groups reflect this variable distribution of SAg genes. Nonetheless, the presently 
observed low overall prevalence of egc– and non-egc SAg genes in PR3-ANCA isolates seems to suggest that 
TSST-1 and other SAgs may have no critical role in GPA.
Differential distribution of leukocidins between PR3-ANCA and MPO-ANCA isolates. Previous 
studies have shown that S. aureus has both a variant and an invariant virulence gene repertoire22. In accordance 
with this notion, major S. aureus virulence genes for leukocidins and hemolysins (pore-forming toxins), includ-
ing lukF, hlgA, hl, hla, hld, hlIII and hlb, were identified in almost all study isolates (Supplementary Information 
Table 1). In contrast, all S. aureus isolates tested negative for the Panton-Valentin leukocidin (PVL). Intriguingly, 
Figure 3. Prevalence of selected genes that were identified before or after correlation analysis of ΔPC1 in 
PR3-ANCA, MPO-ANCA and HC S. aureus isolates. (A) The genes cap-5, cap-8, can, sasG, Q2YUB3, lukX, 
isaB, mprF, set4/ssl10 and set7/ssl2, (B) superantigen-encoding genes, and (C) leukocidin, immune evasion and 
protease genes.
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differences in the prevalence between the three S. aureus sampling groups were observed for several other 
leukocidin genes, including lukD, lukE, lukS, lukX and lukY. Firstly, lukS and lukX were less abundant in the 
MPO-ANCA sampling group only, and secondly, the lukD, lukE and lukY genes were less abundant in both 
the MPO-ANCA and HC sampling group (Fig. 3A and C). Overall, luk genes were most frequently detected in 
the PR3-ANCA sampling group. Noteworthy is also the imbalance in the presence of the lukX and lukY genes 
in the MPO-ANCA and HC sampling groups, while these genes are present at comparable frequencies in the 
PR3-ANCA sampling group. This suggests an association between S. aureus isolates colonizing PR3-GPA patients 
and the possible production of the bi-component LukXY leukocidin (designated LukAB23 and LukGH22). This 
may be relevant since LukXY has strong cytolytic activity and is able to kill neutrophils, macrophages and den-
dritic cells23,24.
For the immune evasion cluster (IEC), which consists of the chp, scn and sak genes on the so-called 
hlb-converting phage, it was noted that many isolates in the PR3-ANCA and MPO-ANCA sampling groups 
lacked the chp gene for the neutrophil chemotaxis-inhibitory protein, while the scn and sak genes for the staph-
ylococcal complement inhibitor and staphylokinase, respectively, were abundantly detected in all sampling 
groups (Fig. 3C). Lastly, the repertoire of protease genes was generally comparable for the three sampling groups, 
although the prevalence of the two protease genes splA and splB was higher in PR3-ANCA isolates than in 
MPO-ANCA and HC isolates (Figs 1 and 3C).
Low levels of anti-staphylococcal antibodies in MPO-ANCA patients. Since PR3-GPA patients 
seem to have difficulties in mounting a humoral immune response against S. aureus11, we also investigated the 
serum IgG levels of MPO-ANCA patients against 38 S. aureus antigens, including 7 surface proteins, 10 secreted 
proteins and 21 secreted superantigens/superantigen-like proteins. The results were compared to antigen specific 
serum IgG levels observed for PR3-ANCA patients and HC. As presented in Fig. 5 and Supplementary Figure 1, 
the overall antibody responses showed a broad variability in all three groups. Importantly, anti-staphylococcal 
IgG responses were comparable in PR3-ANCA and MPO-ANCA patients, and significant differences could only 
be detected between these AAV patients and HC. Both MPO-ANCA and PR3-ANCA patients showed lower 
serum IgG levels against superantigens and superantigen-like proteins (TSST-1, SEN, SEO, SSL1, SSL3, SSL9), 
and against particular staphylococcal surface proteins (ClfA, ClfB, SdrD and SdrE) than HC, though not always 
reaching statistical significance. Conversely, IgG levels against the superantigens SEB, SER and SEM were higher 
in MPO-ANCA patients than in HC as was previously shown for PR3-ANCA patients11. It is noteworthy that the 
relatively low prevalence of the tst-1, sen and seo genes, and the higher prevalence of the seb and ser genes in the 
patient isolates is in perfect agreement with the IgG levels against these antigens. Altogether, these findings show 
that relatively low levels of IgGs against various staphylococcal antigens are a common trait of PR3-ANCA and 
MPO-ANCA patients.
Conclusion
The present study provides a first comprehensive portrait of the gene repertoire of S. aureus isolates from patients 
suffering from the PR3-ANCA- and MPO-ANCA-associated forms of the autoimmune disease AAV. Although 
our retrospective study has some limitations (i.e. relatively low numbers of isolates and patients, or non-matched 
sampling times), the results show that not only the PR3-ANCA-AAV patients, but also the MPO-ANCA-AAV 
patients mainly carry S. aureus types that are carried in the general population. Nevertheless, our results suggest 
a different distribution of S. aureus CCs amongst these two disease types. More importantly, several genetic loci 
of S. aureus were found to be associated with either PR3-ANCA or MPO-ANCA-AAV. In particular, the cap-5, 
sasG and lukX-lukY genes were found to be positively correlated with the PR3-ANCA isolates. These S. aureus 
Figure 4. Hierarchical clustering analysis on the variation within each of the 6 main clonal complexes, as 
described by the first 6 principal components (ΔPC1 – ΔPC6). A complete linkage clustering on the weighted 
results of ΔPC1 – ΔPC6, which together described 83% of the variation present within the entire data set, 
separate nearly all of the S. aureus isolates up into three unique groups. The small group indicated by *, 
represents two S. aureus isolates from CC8 which differ from the rest of CC8 as they are ST72 MRSA isolates, 
and hence form an outlier. ΔPC3 (left) does not strongly distinguish PR3-ANCA (red), MPO-ANCA (blue) and 
HC isolates (green) from one another and hence is represented as the top bar being the least relevant.
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genes could thus be potentially involved in PR3-AAV disease. Crucially, our study provides no evidence for a 
specific SAg profile related to the investigated S. aureus sampling groups but, instead, it suggests a possible role for 
leukocidins in PR3-ANCA-AAV. This is reminiscent of the detrimental effects of these leukocidins on neutrophils 
from which the PR3 and MPO targets of ANCAs are derived. In this respect, it is noteworthy that the chp gene, 
encoding a protein that impairs neutrophil chemotaxis, was negatively correlated to both PR3- and MPO-ANCA 
isolates. This ‘guilt by associations’ makes it conceivable that the specific presence or absence of particular genes 
in S. aureus isolates carried by MPO- and PR3-ANCA-positive AAV patients is relevant for disease onset and 
progression. This could involve a scenario of S. aureus-provoked inflammation, where neutrophil chemotaxis 
is not effectively impaired due to the absence of chp leading to enhanced accumulation of neutrophils, in par-
ticular in the upper respiratory tract. Here, the neutrophils can be activated by ANCA and release their toxic 
products leading to acute inflammation characterized by tissue necrosis and microabscess formation. Such an 
acute neutrophil-rich necrotizing inflammation would evoke a mononuclear leukocyte response promoting gran-
ulomatous inflammation, which is typical for GPA25. The S. aureus cells that provoked the inflammation could 
potentially survive in this neutrophil-rich environment by producing particular leukocidins.
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